Ex-CEO of opioid treatment maker Indivior pleads guilty in U.S.

June 30 (Reuters) - Shaun Thaxter, the former chief executive of drugmaker Indivior Plc, pleaded guilty on Tuesday to a criminal charge arising out of a U.S. Justice Department investigation into the marketing of its opioid addiction treatment Suboxone.

Thaxter pleaded guilty in federal court in Abingdon, Virginia to one count of causing the introduction into interstate commerce of the film version of Suboxone. The plea came a day after the company said he was stepping down as CEO. (Reporting by Nate Raymond in Boston Editing by Chris Reese)


Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.

Sign up for a free trial of our full service at and follow us on Twitter @Breakingviews and at All opinions expressed are those of the authors.